A pilot randomized, double-placebo controlled trial of sublingual or oral immunotherapy for tree nut allergy (TRADE)

舌下或口服免疫疗法治疗树坚果过敏的随机、双安慰剂对照试验（TRADE）

• 批准号: 479399
• 负责人: Chu Derek K
• 金额: $ 34.27万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-03-01 至 2027-03-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=479399&lang=en
• 关键词: Change Patient Care; Desensitization (Immunotherapy); Determine New Treatment Paradigms; Food Allergy; Oral Immunotherapy; Proof Of Principle To Facilitate Larger Phase 3 Studies; Randomized Trial; Sublingual Immunotherapy; Therapy; Tree Nut Allergy

Food allergy is a growing global problem, affecting over 3 million Canadians. Allergies to peanut and tree nuts are the leading causes of food-related allergic reactions and death. Because peanut allergy represents a response to a single food and is there

食物过敏是一个日益增长的全球问题，影响了300万加拿大人。对花生和树坚果的过敏是与食物相关的过敏反应和死亡的主要原因。因为花生过敏代表对单一食物的反应，并且在那里